A proinflammatory peptide from herpes simplex virus type 2 glycoprotein g affects neutrophil, monocyte, and NK cell functions

被引:51
作者
Bellner, L
Thorén, F
Nygren, E
Liljeqvist, JÅ
Karlsson, A
Eriksson, K
机构
[1] Gothenburg Univ, Dept Rheumatol & Inflammat Res, S-41346 Gothenburg, Sweden
[2] Gothenburg Univ, Dept Clin Virol, S-41346 Gothenburg, Sweden
[3] Gothenburg Univ, Dept Med Microbiol & Immunol, S-41346 Gothenburg, Sweden
关键词
D O I
10.4049/jimmunol.174.4.2235
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have identified a synthetic peptide derived from the secreted portion of HSV type 2 glycoprotein G, denoted gG-2p20, which has proinflammatory properties in vitro. The gG-2p20 peptide, corresponding to aa 190-205 of glycoprotein G-2, was a chemoattractant for both monocytes and neutrophils in a dose-dependent fashion, and also induced the release of reactive oxygen from these cells. The receptor mediating the responses was identified as the formyl peptide receptor. The gG-2p20-induced activation of phagocytes had a profound impact on NK cell functions. The reactive oxygen species produced by gG-2p20-activated phagocytes both inhibited NK cell cytotoxicity and accelerated the apoptotic cell death in NK cell-enriched lymphocyte populations. Hence, we have for the first time been able to identify a potential function of the secreted portion of HSV-2 glycoprotein G. We propose that the proinflammatory gG-2p20 peptide identified could contribute to a reduced function and viability of NK cells during HSV-2 infection due to its ability to recruit and activate phagocytic cells.
引用
收藏
页码:2235 / 2241
页数:7
相关论文
共 47 条
[1]   Successful treatment of herpes simplex virus (HSV) recurrent genital infection with recombinant human (rh) granulocyte-macrophage colony stimulating factor (GM-CSF): A case report. [J].
Altamura, M ;
Geronimo, MG ;
Nappi, L ;
Ceci, O ;
Loizzi, P ;
Jirillo, E .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1997, 19 (04) :425-436
[2]   Histaminergic regulation of interferon-gamma (IFN-gamma) production by human natural killer (NK) cells [J].
Asea, A ;
Hansson, M ;
Czerkinsky, C ;
Houze, T ;
Hermodsson, S ;
Strannegard, G ;
Hellstrand, K .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (02) :376-382
[3]   INABILITY OF ENZYME IMMUNOASSAYS TO DISCRIMINATE BETWEEN INFECTIONS WITH HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2 [J].
ASHLEY, R ;
CENT, A ;
MAGGS, V ;
NAHMIAS, A ;
COREY, L .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (07) :520-526
[4]   SYNTHESIS AND PROCESSING OF GLYCOPROTEIN-GG OF HERPES-SIMPLEX VIRUS TYPE-2 [J].
BALACHANDRAN, N ;
HUTTFLETCHER, LM .
JOURNAL OF VIROLOGY, 1985, 54 (03) :825-832
[5]   A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis [J].
Betten, Å ;
Bylund, J ;
Cristophe, T ;
Boulay, F ;
Romero, A ;
Hellstrand, K ;
Dahlgren, C .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (08) :1221-1228
[6]   Oxygen radical-induced natural killer cell dysfunction:: role of myeloperoxidase and regulation by serotonin [J].
Betten, Å ;
Dahlgren, C ;
Mellqvist, UH ;
Hermodsson, S ;
Hellstrand, K .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (06) :1111-1115
[7]   SEVERE HERPESVIRUS INFECTIONS IN AN ADOLESCENT WITHOUT NATURAL-KILLER CELLS [J].
BIRON, CA ;
BYRON, KS ;
SULLIVAN, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (26) :1731-1735
[8]   HSV-2 REPLICATION SITES, MONOCYTE AND LYMPHOCYTIC CELL INFECTION AND VIRION PHAGOCYTOSIS BY NEUTROPHILS, IN VESICULAR LESIONS ON PENILE SKIN - ELECTRONOPTICAL STUDIES OF A BIOPSY [J].
BODDINGIUS, J ;
DIJKMAN, H ;
HENDRIKSEN, E ;
SCHIFT, R ;
STOLZ, E .
JOURNAL OF CUTANEOUS PATHOLOGY, 1987, 14 (03) :165-175
[9]   SEPARATION OF LEUKOCYTES - IMPROVED CELL PURITY BY FINE ADJUSTMENTS OF GRADIENT MEDIUM DENSITY AND OSMOLALITY [J].
BOYUM, A ;
LOVHAUG, D ;
TRESLAND, L ;
NORDLIE, EM .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1991, 34 (06) :697-712
[10]   IMMUNOLOGICAL ALTERATIONS ASSOCIATED WITH RECURRENT HERPES-SIMPLEX GENITALIS [J].
CAUDA, R ;
LAGHI, V ;
TUMBARELLO, M ;
ORTONA, L ;
WHITLEY, RJ .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 51 (02) :294-302